These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 15951295)

  • 1. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
    Peng HL; Hu GY; Zhang GS; Gong FJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density.
    Sadick H; Naim R; Gössler U; Hörmann K; Riedel F
    Int J Mol Med; 2005 Jan; 15(1):15-9. PubMed ID: 15583822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma level and tissue expression of angiogenic factors in patients with hereditary hemorrhagic telangiectasia.
    Sadick H; Naim R; Sadick M; Hörmann K; Riedel F
    Int J Mol Med; 2005 Apr; 15(4):591-6. PubMed ID: 15754019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
    Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia.
    Giordano P; Lenato GM; Pierucci P; Suppressa P; Altomare M; Del Vecchio G; Di Bitonto G; De Mattia D; Guanti G; Sabbà C
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):577-82. PubMed ID: 19636272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
    Vural P; Degirmencioglu S; Erden S; Gelincik A
    Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
    Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
    Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor function in the endothelium.
    Lebrin F; Deckers M; Bertolino P; Ten Dijke P
    Cardiovasc Res; 2005 Feb; 65(3):599-608. PubMed ID: 15664386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
    Seki T; Yun J; Oh SP
    Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the genotype of HHT patients with mutations of the ENG and ACVRL1 gene correlate to different expression levels of the angiogenic factor VEGF?
    Sadick H; Hage J; Goessler U; Bran G; Riedel F; Bugert P; Hoermann K
    Int J Mol Med; 2008 Nov; 22(5):575-80. PubMed ID: 18949376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
    von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
    Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
    Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
    Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.